Source: Arranta Bio Blog

Arranta Bio Blog Join Us! Microbiome Movement Drug Development, June 28-30, 2023, Boston, USA

We are excited to be exhibiting at Microbiome Movement Drug Development, taking place June 28-30, 2023 in Boston, USA. Arranta and Vibalogics offer CDMO capabilities from preclinical to clinical and commercial approval for new biological modalities encompassing technologies based on live viruses and viral vectors, live-microbial biopharmaceutical products, nucleic acid-based mRNA and plasmid DNA production. [...]The post Join Us! Microbiome Movement Drug Development, June 28-30, 2023, Boston, USA appeared first on ArrantaBio.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Mark Bamforth's photo - Founder & CEO of Arranta Bio

Founder & CEO

Mark Bamforth

CEO Approval Rating

84/100

Read more